Overview

Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection

Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor super-agonist (N-803) in Individuals with Acute HIV Infection
Phase:
Phase 2
Details
Lead Sponsor:
Thai Red Cross AIDS Research Centre
Collaborators:
Henry M. Jackson Foundation for the Advancement of Military Medicine
Walter Reed Army Institute of Research (WRAIR)